FDA Approved: OXYTROL FOR WOMEN — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approval of a supplemental application for OXYTROL FOR WOMEN (oxybutynin) from Allergan, Inc. to modify or expand the product's regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• OXYTROL FOR WOMEN (OXYBUTYNIN)

Snippet

SUPPL AP for OXYTROL FOR WOMEN (OXYBUTYNIN)